Hyundai Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	910,426	561,851	1,038,982	1,087,244	976,101	1,048,678
Market Cap Growth	51.42%	-45.92%	-4.44%	11.39%	-6.92%	115.45%
Enterprise Value	881,067	579,143	1,031,571	1,069,527	969,321	1,050,097
Last Close Price	9480.00	7055.00	12295.97	12908.41	11895.53	13756.41
PS Ratio	464.43	37.33	109.58	138.48	105.62	83.82
PB Ratio	8.26	14.25	22.95	18.67	15.85	20.04
P/TBV Ratio	15.67	89.63	73.68	43.38	34.98	81.02
P/FCF Ratio	-	269.15	-	-	-	-
P/OCF Ratio	-	248.93	-	-	-	139.79
EV/Sales Ratio	-	38.48	108.80	136.22	104.89	83.93
EV/EBITDA Ratio	-	406.48	-	-	-	-
EV/EBIT Ratio	-	732.19	-	-	-	-
EV/FCF Ratio	-24.88	277.44	-	-	-	-
Debt / Equity Ratio	0.03	0.67	0.12	0.11	0.25	0.71
Debt / EBITDA Ratio	-	18.66	-	-	-	-
Debt / FCF Ratio	-	12.74	-	-	-	-
Asset Turnover	0.02	0.25	0.16	0.11	0.11	0.16
Inventory Turnover	1.44	1.78	1.62	1.63	1.59	1.19
Quick Ratio	5.94	0.14	1.77	2.23	1.73	3.41
Current Ratio	6.40	0.25	2.18	2.67	2.02	4.37
Return on Equity (ROE)	-28.52%	-16.36%	-28.02%	-26.39%	-35.21%	-16.50%
Return on Assets (ROA)	-11.01%	0.82%	-10.20%	-22.24%	-6.66%	-3.51%
Return on Invested Capital (ROIC)	-20.25%	1.56%	-23.13%	-52.30%	-14.85%	-7.12%
Return on Capital Employed (ROCE)	-14.90%	2.00%	-21.40%	-45.10%	-14.70%	-5.30%
Earnings Yield	-2.41%	-1.23%	-1.40%	-1.45%	-2.05%	-0.79%
FCF Yield	-3.89%	0.37%	-0.63%	-1.66%	-0.44%	-1.69%
Buyback Yield / Dilution	-140.29%	-0.10%	-1.04%	-6.64%	-2.79%	-3.67%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.